Catalyst Wire Dossier Catalyst Wire Dossier

Lumigan

bimatoprost · AbbVie Deutschland GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for Lumigan, covering 2007-12-05 to 2024-11-18. Get the full timeline:

Most recent: EMA Authorised: Lumigan (bimatoprost) — AbbVie Deutschland GmbH & Co. KG

See pricing